News

New Upright Shipping Case Design for Vapor Shippers

An IC Biomedical CX100 Vapor Shipper will maintain cryogenic temperatures for up to 20 days if kept in an upright position. Unfortunately, if the shipper is oriented sideways during transit and handling it can cut this time by up to 50%. With shipping times getting longer and package handling getting rougher, IC Biomedical has designed a new Case that provides a safer, more secure enclosure for nitrogen vapor shippers.


The new IC BIomedical Shipping Case is made of high-impact-resistant material to protect its contents from physical damage. The Case’s domed top prevents stacking and its circular wide base encourages upright orientation during handling and transit.


Designed for IC Biomedical shippers 4D, 4DX, CX100 and CXR100, the Shipping Case is also compatible with most other similar-sized shippers available on the market. A built-in slot allows the case to be locked down for added sample security.


Height: 24-inches
Base Diameter: 15-inches
Weight: 14

IC Biomedical Builds Medical-Grade Manufacturing Facility in Cartersville, Georgia

IC Biomedical, a producer of cryogenic freezers, will make a multi-million dollar investment in opening an advanced manufacturing facility near Cartersville, Georgia. The project is expected to create more than 80 jobs in Bartow County.

The company will operate in a recently constructed 75,000-square-foot facility located on Cass-White Road. According to state officials, the demand for medical-grade freezers continues to surge.

“IC Biomedical is committed to manufacturing class-leading products with innovation, quality, and technical excellence,” said CEO of IC Biomedical Steve Shaw. “Georgia was the obvious choice for us, a highly trained workforce, transport links, and a state infrastructure committed to the life science sector that is able to support our business in a way no other location could offer.”

“Recent events have proven the importance of IC Biomedical’s products within our global health ecosystems,” said GDEcD Commissioner Pat Wilson. “Home to top-ranked research universities and organizations including the Centers for Disease Control and Prevention and the Task Force for Global Health, Georgia is a hotbed for every aspect of the life sciences industry, from research and development to production and distribution. I’m confident IC Biomedical will find great success here, and I thank Steve Shaw for reinvesting in his hometown.”

IC Biomedical manufactures premium cryogenic equipment, including stainless steel and aluminum freezers, Dewars, shippers, and other custom equipment used for safe storage and transportation of medical products such as vaccines, therapies, and other biological specimens.

“Congratulations to IC Biomedical on the selection of Cartersville for their new manufacturing facility,” said Katie Kirkpatrick, president and CEO of the Metro Atlanta Chamber. “We are pleased to have IC Biomedical join metro Atlanta’s growing life sciences community with assets like Emory School of Medicine, Morehouse School of Medicine, Centers for Disease Control and Prevention, Georgia Tech and the many businesses engaged in research, development, manufacturing, and distribution of life science related products and supplies.”

https://www.areadevelopment.com/newsitems/5-20-2021/ic-biomedical-manufacturing-cartersville-georgia.shtml

Milton Street Capital Forms IC Biomedical, Simultaneously Acquires The Life Sciences Business of Worthington Industries and International Cryogenics, Inc.

October 30, 2020

Milton Street Capital, a Houston-based lower middle market private equity firm, today announced the simultaneous acquisition of the Life Sciences business of Worthington Industries and International Cryogenics, Inc. Following the closing, these two cryogenic biomedical equipment manufacturers will operate under IC Biomedical (ICBiomedical.com)  

The Life Sciences business of Worthington Industries (“Life Sciences”), located in Theodore, AL, is a market leading manufacturer of cryogenic stainless steel and aluminum storage freezers, dewars and shippers used to store biological specimens. The Life Sciences business was previously owned by Taylor-Wharton, which sold its biomedical storage products under the “CryoScience by Taylor-Wharton” brand.  The business has a 50-year legacy of supplying high quality products to the demanding global biomedical research and development, healthcare, biorepository, pharmaceutical, biotechnology, IVF and animal breeding markets.    

International Cryogenics, Inc. (“ICI”), based in Indianapolis, IN, is a manufacturer of cryogenic aluminum, freezers, dewars, shippers and custom products for biomedical applications. With a long history dating back over 40 years, ICI is a well-known as a high quality manufacturer in the industry.

IC Biomedical will be led by Steve Shaw, CEO and Jim Hoppel, CFO.   Steve has over 25 years of cryogenic biomedical market experience that includes President of  of Chart Industries’ former BioMedical Group (MVE and Caire). Jim was formally the CAO and VP, Corporate Development at Chart Industries and CFO at Taylor-Wharton.

“We are thrilled to partner with Steve and Jim to form IC Biomedical. The combination of Steve’s leadership experience and well-known market presence, and Life Sciences’ and ICI’s long history of manufacturing high quality cryogenic biomedical storage products makes this an excellent fit,” said Francis Carr, a Managing Partner at Milton Street. “Biomedical cold storage is a high growth sector, and we are excited to partner with an industry-leading management team to build a company that is both customer focused and operationally excellent.” 

“Milton Street’s experience in complex corporate carve-out transactions made them the ideal partner for combining Worthington’s Life Sciences business and ICI,” said Steve Shaw, CEO of IC Biomedical. “We look forward to executing on our vision to build a leading biomedical cold storage business. The merger of these two established businesses provides an unequalled platform to serve an ever growing and more demanding biomedical market. We will manufacture in a medical device accredited facility providing products with the highest regulatory compliance and quality. The distribution partners and customers of IC Biomedical can be assured that we will provide an increased level of support and partnership moving forward with a program of new product development and a significant investment in quality.”

About Milton Street Capital

Milton Street Capital is a Houston-based private equity firm that targets control investments in North American-based, lower middle-market industrial manufacturing, distribution and services companies. Milton Street has a bias towards overlooked and underinvested companies where there is a significant opportunity to drive value creation through commercial and operational improvements. This will be the third platform investment from Milton Street Capital Fund I.  For further information, please visit www.miltonstreetcap.com.